SCHEMBL17693661

SCHEMBL17693661

Cc1ccc(Nc2ccc(Nc3ccc(Cl)cc3C)c3c2C(=O)c2ccccc2C3=O)c(C)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY4 P51582 4/20 0.61
▸ P2RY2 P41231 3/20 0.57
▸ RAB9A P51151 3/20 0.56
▸ MAPK1 P28482 5/20 0.50
▸ MAPT P10636 5/20 0.50
▸ TDP1 Q9NUW8 4/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ HTT P42858 2/20 0.50
▸ MET P08581 2/20 0.46
▸ LMNA P02545 2/20 0.45
▸ NPSR1 Q6W5P4 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ POLB P06746 3/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ ELANE P08246 1/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ APAF1 O14727 1/20 0.42
▸ TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6055493 0.91 P2RY4 (0.64) P2RY4P2RY2RAB9AMAPK1MAPT
SCHEMBL13345996 0.86 P2RY4 (0.59) P2RY4P2RY2RAB9AMAPK1MAPT
SCHEMBL20520388 0.84 RAPGEF4 (0.63) P2RY4P2RY2RAB9AMAPK1MAPT
SCHEMBL8947580 0.83 P2RY4 (0.57) P2RY4P2RY2RAB9AMAPK1MAPT
SCHEMBL11536541 0.83 P2RY4 (0.63) P2RY4P2RY2RAB9AMAPK1MAPT
SCHEMBL11536975 0.82 MAOA (0.57) P2RY4P2RY2RAB9AMAPK1MAPT
SCHEMBL13346031 0.82 P2RY4 (0.54) P2RY4P2RY2RAB9AMAPK1MAPT
SCHEMBL11134846 0.81 RAB9A (0.55) P2RY4P2RY2RAB9AMAPK1MAPT
SCHEMBL17695808 0.81 P2RY4 (0.50) P2RY4P2RY2MAPTTDP1MEN1
SCHEMBL23787875 0.80 P2RY4 (0.60) P2RY4P2RY2RAB9AMAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9504637-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-11-29 — — US disclosed
US-20160106648-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2016-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160106648-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 P2RY4 4422/4885P2RY2 4676/4885RAB9A 3476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback